Today: 30 April 2026
Bradesco stock price nears $4: what to watch after the payout tweak and Brazil rate bets
25 January 2026
2 mins read

Bradesco stock price nears $4: what to watch after the payout tweak and Brazil rate bets

SAO PAULO, Jan 25, 2026, 08:15 BRT — The market has closed.

Banco Bradesco S.A.’s American depositary shares (NYSE: BBD) climbed 2.5% to close at $3.95 on Friday, hitting a session peak of $3.97 earlier in the day.

The late-week rally followed a new shareholder-payments update from the Brazilian lender. This came amid ongoing chatter about yield and the bigger issue: the timing of Brazil’s rate cycle shift.

Timing is crucial here. Bradesco distributes monthly payments to shareholders through “interest on shareholders’ equity,” which works like a dividend. Even slight shifts in these net payouts can sway valuation models, especially as the market is actively recalculating cash returns.

In a Form 6-K dated Jan. 23, Bradesco announced an adjustment to the income tax rate and net per-share values for its 2026 monthly “interest on shareholders’ equity” payments, following the release of Supplementary Law No. 224/25. The bank kept the gross monthly payments steady at R$0.017249826 per common share and R$0.018974809 per preferred share. Net amounts were set at R$0.014231106 and R$0.015654217, reflecting a 17.5% withholding tax. Signed by investor relations officer André Costa Carvalho, the notice confirmed the payment schedule would “remain unchanged,” with the January reference-month payment slated for Feb. 2.

Interest on shareholders’ equity — known as JCP in Brazil — functions as a cash payout to investors but is taxed differently than a regular dividend under local rules. That means changes to tax rates quickly affect what shareholders end up with.

Rates remain the key focus. A Reuters poll on Friday revealed economists are betting Brazil’s central bank will keep the Selic rate steady at 15% on Jan. 28, with most expecting the first cut to arrive in March. Stephan Kautz, chief economist at EQI Asset, noted the upcoming statement might drop language about resuming hikes. Meanwhile, BNP Paribas economist Laiz Carvalho pointed to household spending as the growth driver, fueled by consumption stimulus measures set for late 2025 and early 2026.

This environment is crucial for Bradesco and other major Brazilian banks, as rate cuts can boost credit demand and make debt payments more manageable, though they also squeeze the lending spreads these banks rely on. Itaú Unibanco, Banco do Brasil, and Santander Brasil usually follow similar policy cues.

Bradesco’s next key event is just around the corner. The bank remains in a quiet period until Feb. 5, when it will report its fourth-quarter results after the close in São Paulo and New York, per its investor relations calendar. A videoconference to discuss the earnings is scheduled for Feb. 6 at 08:30 a.m. U.S. Eastern time, with simultaneous English translation provided.

As the numbers come in, traders will zero in on loan growth, bad loan provisions, and whether profits are still nudging up. A shift in the tone on capital returns could steal the spotlight from the mechanical payout adjustment revealed last week.

There’s a clear risk, though: inflation expectations might stop falling, keeping policymakers cautious and rates pinned at 15% longer than markets anticipate. That scenario would maintain steep borrowing costs, putting pressure on weaker borrowers—a combination that has weighed on Brazilian bank sentiment in the past.

The next key event is the central bank decision on Jan. 28, followed by Bradesco’s earnings report on Feb. 5. Policymakers’ language and the bank’s outlook on credit and margins will drive what happens next.

Stock Market Today

  • KalVista Pharmaceuticals Rises 39% on Acquisition Deal with Chiesi Group
    April 29, 2026, 6:37 PM EDT. KalVista Pharmaceuticals surged 38.62% to $26.67 after announcing its acquisition by Italy's Chiesi Group at $27 per share in cash. The deal sparked high trading volume, reaching 69.4 million shares, over 3,000% above average. KalVista, known for its oral therapy EKTERLY for hereditary angioedema, could benefit from Chiesi's global reach. The broader market was mixed: the S&P 500 dipped 0.02% to 7,138, while the Nasdaq edged up 0.04% to 24,673. Rival biotech stock Prothena dropped 5.56% amid investor caution over drug pipelines. KalVista's acquisition marks a shift for a company that faced heavy short interest and revenue challenges, positioning it for growth under Chiesi's ownership, pending regulatory approval.

Latest article

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

30 April 2026
Markel Group posted a $212.3 million net loss for the first quarter, driven by a $728 million investment loss, sending shares down 7.9% to $1,759.21. Operating revenue held steady at $3.55 billion, while adjusted operating income rose 4% to $498 million. Markel Insurance’s adjusted operating income jumped 31% to $369 million. Gross premium volume in underwriting fell 21% after exiting Global Reinsurance.
QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

30 April 2026
The Invesco QQQ Trust closed up $3.99 at $661.57 Wednesday as investors positioned ahead of earnings from Microsoft, Alphabet, Amazon, and Meta. Volume topped 30 million shares. Microsoft and Alphabet reported strong cloud and AI-driven revenue growth after the bell. The broader Nasdaq Composite edged up 0.04%, while the S&P 500 slipped 0.04%.
Intel stock price tumbles 17% on outlook shock — what to watch before Monday’s open
Previous Story

Intel stock price tumbles 17% on outlook shock — what to watch before Monday’s open

AMD stock closes higher into Monday as Intel stumbles; what investors watch next
Next Story

AMD stock closes higher into Monday as Intel stumbles; what investors watch next

Go toTop